Triple-negative breast cancer (TNBC), an aggressive subtype of breast tumor that lacks hormone receptor expression and HER2 gene amplification, accounts for 12%–18% of breast neoplasms (Foulkes et al., 2010). The gene discussed is ERBB2; the disease is breast neoplasm.